Add BrightSurf on Google Email

JCI Journals


Combination therapy for acute lymphoblastic leukemia

Researchers at St. Jude Children's Research Hospital discovered that combining tyrosine kinase inhibitors with an FAK inhibitor synergizes to decrease tumor growth in mouse models of BCR-ABL1+ B-progenitor ALL. This combination approach is a promising treatment strategy for this subset of ALL.

SourceJCI Journals·JournalJCI Insight·DateApr 7, 2016

Improving models of chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL) researchers have improved their models of the disease by understanding how cancer cells differentiate into antibody-secreting plasma cells in mice. Patient-derived T cells play a crucial role in this process, and therapies promoting differentiation may offer new treatment options for CLL.

SourceJCI Journals·JournalJCI Insight·DateApr 7, 2016

Group B Streptococcus breaches the blood-brain-barrier

A new study reveals Group B Streptococcus induces a protein that disrupts junctions between brain cells, increasing permeability and allowing the bacteria to breach the blood-brain barrier. Inhibition of this protein increases survival in zebrafish infected with GBS.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 11, 2015

Identification of drug combinations that reverse HIV-1 latency

Researchers have developed a multifaceted approach to identify drug combinations that reverse HIV-1 latency. Several 2-drug combinations were found to be able to reactivate HIV-1 without triggering an inflammatory response, and a model was created to correlate changes in viral RNA with virus secretion from T cells.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 30, 2015

Insulin resistance linked to a human gene variant

A new study identifies N-acetyltransferase 2 as a key gene variant linked to insulin resistance, increasing the risk of type 2 diabetes and cardiovascular disease. Inhibition of NAT2 in a mouse model decreased insulin sensitivity, highlighting its role in complex diseases.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 23, 2015